Christopher Halfpenny

1.9k total citations
10 papers, 172 citations indexed

About

Christopher Halfpenny is a scholar working on Developmental Neuroscience, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher Halfpenny has authored 10 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Developmental Neuroscience, 5 papers in Pathology and Forensic Medicine and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher Halfpenny's work include Neurogenesis and neuroplasticity mechanisms (6 papers), Multiple Sclerosis Research Studies (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Christopher Halfpenny is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (6 papers), Multiple Sclerosis Research Studies (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Christopher Halfpenny collaborates with scholars based in United Kingdom, United States and Australia. Christopher Halfpenny's co-authors include Neil Scolding, Claire M Rice, Karen Luyt, Anikó Váradi, Elek Molnár, George Tackley, Fanny O’Brien, Mark Woodhall, Maria Isabel Leite and Patrick Waters and has published in prestigious journals such as Brain, Neurology and The Lancet Neurology.

In The Last Decade

Christopher Halfpenny

9 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Halfpenny United Kingdom 7 62 54 51 48 33 10 172
Lukas Enz Switzerland 6 97 1.6× 82 1.5× 50 1.0× 76 1.6× 34 1.0× 7 308
Aneek Patel United States 6 25 0.4× 104 1.9× 49 1.0× 116 2.4× 27 0.8× 26 271
Douglas Landsman United States 4 70 1.1× 19 0.4× 33 0.6× 54 1.1× 38 1.2× 5 175
Helena Kronsbein Germany 6 114 1.8× 18 0.3× 26 0.5× 68 1.4× 43 1.3× 6 240
Daniela Ungaro Italy 10 48 0.8× 22 0.4× 118 2.3× 107 2.2× 66 2.0× 12 304
Ashley McDonough United States 10 84 1.4× 57 1.1× 60 1.2× 86 1.8× 29 0.9× 14 341
James S. Choi United States 7 108 1.7× 67 1.2× 54 1.1× 119 2.5× 16 0.5× 12 289
Armelle Klopstein Switzerland 6 55 0.9× 41 0.8× 30 0.6× 136 2.8× 20 0.6× 6 305
Rosana-Bristena Ionescu United Kingdom 6 26 0.4× 40 0.7× 29 0.6× 49 1.0× 11 0.3× 9 136
Nicholas J. Kuypers United States 7 42 0.7× 177 3.3× 65 1.3× 182 3.8× 35 1.1× 8 348

Countries citing papers authored by Christopher Halfpenny

Since Specialization
Citations

This map shows the geographic impact of Christopher Halfpenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Halfpenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Halfpenny more than expected).

Fields of papers citing papers by Christopher Halfpenny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Halfpenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Halfpenny. The network helps show where Christopher Halfpenny may publish in the future.

Co-authorship network of co-authors of Christopher Halfpenny

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Halfpenny. A scholar is included among the top collaborators of Christopher Halfpenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Halfpenny. Christopher Halfpenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yeh, Wei Zhen, Waqar Rashid, JC Hobart, et al.. (2026). Optimal strategies for treatment discontinuation in MOG antibody-associated disease. Brain.
2.
Chen, Bo, Susan M. Cooper, Ruth Dobson, et al.. (2024). Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder. Neurology. 104(1). e210137–e210137. 1 indexed citations
3.
Tackley, George, Fanny O’Brien, João Carlos da Rocha, et al.. (2016). Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment. Multiple Sclerosis and Related Disorders. 7. 21–25. 31 indexed citations
4.
Street, Duncan, Christopher Halfpenny, & Ian Galea. (2014). CNS inflammation other than multiple sclerosis: How likely is diagnosis?. Neurology. 82(13). 1187–1189. 6 indexed citations
5.
Luyt, Karen, Anikó Váradi, Christopher Halfpenny, Neil Scolding, & Elek Molnár. (2004). Metabotropic glutamate receptors are expressed in adult human glial progenitor cells. Biochemical and Biophysical Research Communications. 319(1). 120–129. 24 indexed citations
6.
Rice, Claire M, Christopher Halfpenny, & Neil Scolding. (2004). Cell therapy in demyelinating diseases. PubMed. 1(4). 415–423. 7 indexed citations
7.
Halfpenny, Christopher. (2003). Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro. Journal of Neuroimmunology. 139(1-2). 9–16. 12 indexed citations
8.
Rice, Claire M, Christopher Halfpenny, & Neil Scolding. (2003). Stem cells for the treatment of neurological disease. Transfusion Medicine. 13(6). 351–361. 22 indexed citations
9.
Halfpenny, Christopher, et al.. (2002). Cell transplantation, myelin repair, and multiple sclerosis. The Lancet Neurology. 1(1). 31–40. 39 indexed citations
10.
Halfpenny, Christopher, et al.. (2001). Glial cells as targets for cytotoxic immune mediators. Glia. 36(2). 200–211. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lukas Enz Breakdown of academic impact, for papers by Aneek Patel Breakdown of academic impact, for papers by Douglas Landsman Breakdown of academic impact, for papers by Helena Kronsbein Breakdown of academic impact, for papers by Daniela Ungaro Breakdown of academic impact, for papers by Ashley McDonough Breakdown of academic impact, for papers by James S. Choi Breakdown of academic impact, for papers by Armelle Klopstein Breakdown of academic impact, for papers by Rosana-Bristena Ionescu Breakdown of academic impact, for papers by Nicholas J. Kuypers
Rankless by CCL
2026